secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001562762-24-000163
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical shareholders approve amendment to 2021 Equity Incentive Plan
---------------------------------------------------------------------------

- Plan amendment approved with 244,115,224 votes for, 78,950,353 against; effective June 5, 2024.
- Material features described in Proxy Statement filed April 26, 2024, incorporated by reference.
- Directors elected: Davidar (263.7M for), Tobin (256.5M), Zarrilli (320.0M), Wolterman (322.5M).
- Ratification of Deloitte as auditor (329.3M for) and non-binding say-on-pay approved (315.4M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276224000163/0001562762-24-000163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276224000163/gmed-20240605x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-24-000163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer